Identification of a Glycogen Synthase Kinase-3β Inhibitor that Attenuates Hyperactivity in CLOCK Mutant Mice

Bipolar disorder is characterized by a cycle of mania and depression, which affects approximately 5 million people in the United States. Current treatment regimes include the so-called “mood-stabilizing drugs”, such as lithium and valproate that are relatively dated drugs with various known side eff...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kozikowski, Alan P., Gunosewoyo, Hendra, Guo, Songpo, Gaisina, Irina N., Walter, Richard L., Ketcherside, Ariel, McClung, Colleen A., Mesecar, Andrew D., Caldarone, Barbara
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3428230/
https://ncbi.nlm.nih.gov/pubmed/21732538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.201100188
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak